Literature DB >> 9404711

The National Cancer Data Base report on gastric carcinoma.

S A Hundahl1, H R Menck, E G Mansour, D P Winchester.   

Abstract

BACKGROUND: The National Cancer Data Base (NCDB) represents a national electronic registry system now encompassing almost 60% of incident cancers in the United States. In combination with other programs of the American College of Surgeons Commission on Cancer, the NCDB offers a working example of voluntary, accurate, and cost-effective "outcomes management" on a both a local and a national scale.
METHODS: For the accession years 1985-1993, the NCDB has obtained information on demographics, patterns of care, disease stage, treatment, and outcome for a convenience sample of 57,407 gastric carcinoma cases (1.6% of total NCDB cases). In addition to describing trends, this report focuses on 5-year relative survival for a cohort of 1987-1988 cases staged according to the third edition of the American Joint Committee on Cancer's TNM classification, as well as patterns of care for a cohort of 1992-1993 cases.
RESULTS: Stage-stratified 5-year relative survival for the 1987-1988 cohort was as follows: IA, 71%; IB, 56%; II, 37%; IIIA, 18%; IIIB, 11%; IV, 5%. Without noteworthy changes in stage distribution, demographics, or other factors, the proportion of patients treated by total gastrectomy is increasing slightly, but proximal gastrectomy for proximal cancers remains surprisingly popular. The proportion of cases receiving postoperative adjuvant treatment has declined slightly. Presumably because of advanced age and/or medical infirmity, a substantial proportion of U.S. patients with disease at every stage receive no treatment for cancer.
CONCLUSIONS: This analysis of patterns of care has revealed unexplained variations in treatment and opportunities for improvement. Treatment of the elderly, infirm patient with gastric carcinoma appears problematic.

Entities:  

Mesh:

Year:  1997        PMID: 9404711     DOI: 10.1002/(sici)1097-0142(19971215)80:12<2333::aid-cncr15>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

Review 1.  Magnifying endoscopy in upper gastroenterology for assessing lesions before completing endoscopic removal.

Authors:  Ning-Li Chai; En-Qiang Ling-Hu; Yoshinori Morita; Daisuke Obata; Takashi Toyonaga; Takeshi Azuma; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

2.  Prognostic significance of peritoneal lavage cytology in gastric cancer in Singapore.

Authors:  Esther W L Chuwa; Lay-Wai Khin; Weng-Hoong Chan; Hock-Soo Ong; Wai-Keong Wong
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 3.  Current role of surgical therapy in gastric cancer.

Authors:  Ryan Swan; Thomas J Miner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

4.  Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line.

Authors:  Bin Wu; Qiang Zhang; Weiming Shen; Jun Zhu
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

5.  Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Authors:  F Bozzetti; E Marubini; G Bonfanti; R Miceli; C Piano; L Gennari
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

6.  Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis.

Authors:  Jingyu Deng; Han Liang; Dan Sun; Yi Pan; Yong Liu; Dianchang Wang
Journal:  Langenbecks Arch Surg       Date:  2011-03-05       Impact factor: 3.445

7.  First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?

Authors:  Ricardo Marcos-Pinto; Mário Dinis-Ribeiro; Fátima Carneiro; José Carlos Machado; Ceu Figueiredo; Celso A Reis; José Ferreira; Jorge Areias
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

8.  Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.

Authors:  Steven C Cunningham; Farin Kamangar; Min P Kim; Sommer Hammoud; Raqeeb Haque; Anirban Maitra; Elizabeth Montgomery; Richard E Heitmiller; Michael A Choti; Keith D Lillemoe; John L Cameron; Charles J Yeo; Richard D Schulick
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

9.  Risk factors for postoperative pneumonia after gastrectomy for gastric cancer.

Authors:  Yuichiro Miki; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  Surg Today       Date:  2015-06-16       Impact factor: 2.549

10.  The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis.

Authors:  Kai-Tai Liu; Jue-Feng Wan; Gen-Hua Yu; Yan-Ping Bei; Xue Chen; Miao-Zhen Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-18       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.